This site is intended for health professionals only

Wednesday 19 June 2019
Share |

Latest News

Lynparza approved for first-line maintenance treatment of BRCA-mutated advanced ovarian cancer

Tuesday 18th June 2019
AstraZeneca and MSD have announced that the European Commission (EC) has approved Lynparza (olaparib) as a 1st-line maintenance treatment for women with BRCA-mutated advanced ovarian cancer.
The licensed indication is as a maintenance treatment of adult patients with advanced (FIGO stages III and IV) BRCA1/2-mutated (germline and/or somatic) high-grade epithelial ovarian, fallopian tube or primary peritoneal cancer who are in response (...
Wed, 20 Mar 2019
One in four people with coeliac disease were previously misdiagnosed with IBS
Tue, 19 Mar 2019
Study shows that Emergency Department Pharmacist Practitioners can combine traditional clinical pharmacy with more hands-on medical practice including being designated care providers
Mon, 18 Mar 2019
Professor Evelien Dekker discusses the rising burden of colorectal cancer in Europe and the need for consistent and successful screening programmes across the continent
Mon, 18 Mar 2019
The REPAIR study showed that treatment with macitentan was associated with significant improvement in RV function in patients with PAH
Mon, 18 Mar 2019
44-week UNIFI data presented for the first time during plenary session at 14th Congress of the European Crohn’s and Colitis Organisation
Fri, 15 Mar 2019
Research led by the Royal College of Surgeons in Ireland (RCSI) has been awarded €7m to investigate new treatments for Parkinson’s over three years.
Thu, 7 Mar 2019
A report commissioned by the European Biosafety Network was launched at a roundtable on preventing exposure to hazardous drugs in healthcare, held in the European Parliament in Brussels attended by MEPs, unions, employers, professional associations, representatives of Member States and the European Commission